Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents. | Molecules | 2022 | 36235168 | PubTator, text mining | PubMed |
| Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach. | Molecules | 2022 | 36235128 | PubTator, text mining | PubMed |
| A Common Variant in the CDK8 Gene Is Associated with Sporadic Pituitary Adenomas in the Portuguese Population: A Case-Control Study. | Int J Mol Sci | 2022 | 36233050 | PubTator, text mining | PubMed |
| Current understanding of epigenetics role in melanoma treatment and resistance. | Cancer Cell Int | 2022 | 36224606 | PubTator, text mining | PubMed |
| Circular RNA-regulated autophagy is involved in cancer progression. | Front Cell Dev Biol | 2022 | 36187468 | PubTator, text mining | PubMed |
| Urea-based anticancer agents. Exploring 100-years of research with an eye to the future. | Front Chem | 2022 | 36186578 | PubTator, text mining | PubMed |
| Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML). | Genes Dis | 2022 | 36157504 | PubTator, text mining | PubMed |
| Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities. | Genes Dis | 2022 | 36157489 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. | Viruses | 2022 | 36146786 | PubTator, text mining | PubMed |
| Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery. | Cancers (Basel) | 2022 | 36139513 | PubTator, text mining | PubMed |
| Circular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation. | Onco Targets Ther | 2022 | 36134387 | PubTator, text mining | PubMed |
| EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report. | Front Oncol | 2022 | 36132152 | PubTator, text mining | PubMed |
| The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance. | Front Oncol | 2022 | 36132137 | PubTator, text mining | PubMed |
| Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy. | J Med Chem | 2022 | 36126227 | PubTator, text mining | PubMed |
| Graphene-incorporated hyaluronic acid-based hydrogel as a controlled Senexin A delivery system. | Biomater Transl | 2022 | 36105568 | PubTator, text mining | PubMed |
| Mitochondrial stress induces AREG expression and epigenomic remodeling through c-JUN and YAP-mediated enhancer activation. | Nucleic Acids Res | 2022 | 36095121 | PubTator, text mining | PubMed |
| Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma. | Front Pharmacol | 2022 | 36091765 | PubTator, text mining | PubMed |
| The anti-androgenic fungicide triticonazole induces region-specific transcriptional changes in the developing rat perineum and phallus. | Chemosphere | 2022 | 36084822 | PubTator, text mining | PubMed |
| The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma. | Cells | 2022 | 36078096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=21